Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication

Background. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the...

Full description

Saved in:
Bibliographic Details
Main Authors: Sung Min Jung, Dae Young Cheung, Jin Il Kim, Il Kim, Hyeonjin Seong
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2016/1293649
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567321259933696
author Sung Min Jung
Dae Young Cheung
Jin Il Kim
Il Kim
Hyeonjin Seong
author_facet Sung Min Jung
Dae Young Cheung
Jin Il Kim
Il Kim
Hyeonjin Seong
author_sort Sung Min Jung
collection DOAJ
description Background. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the first-line therapy of H. pylori eradication. Methods. We reviewed medical records of patients who were confirmed to have H. pylori infection and received eradication treatment from September 2012 to March 2015. The concomitant group was treated with rabeprazole, amoxicillin, clarithromycin, and metronidazole for 7 days. The sequential group was treated with rabeprazole and amoxicillin for 5 days and then rabeprazole, clarithromycin, and metronidazole for an additional 5 days. Six weeks after the treatment period, patients in both groups underwent 13C-Urea breath test (UBT) to confirm H. pylori eradication. Results. The eradication rate was 90.3% in the concomitant group and 85.5% in the sequential group. However, the eradication rates between the two groups showed no statistical difference (P=0.343). Conclusion. No statistical difference was found in eradication rates between the two groups. However, in areas where antibiotic resistance is high, concomitant therapy may be more effective than sequential therapy for H. pylori eradication.
format Article
id doaj-art-95353d553c7e4a2681b95e37b1cd6efc
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-95353d553c7e4a2681b95e37b1cd6efc2025-02-03T01:01:48ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/12936491293649Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori EradicationSung Min Jung0Dae Young Cheung1Jin Il Kim2Il Kim3Hyeonjin Seong4Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul KS013, Republic of KoreaDivision of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul KS013, Republic of KoreaDivision of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul KS013, Republic of KoreaDivision of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul KS013, Republic of KoreaDivision of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul KS013, Republic of KoreaBackground. The decline of Helicobacter pylori (H. pylori) eradication rates with standard triple therapy resulted in a search for novel therapies for first-line therapy of H. pylori infection. Aim. The aim of the study is to compare the efficacy of concomitant therapy with sequential therapy as the first-line therapy of H. pylori eradication. Methods. We reviewed medical records of patients who were confirmed to have H. pylori infection and received eradication treatment from September 2012 to March 2015. The concomitant group was treated with rabeprazole, amoxicillin, clarithromycin, and metronidazole for 7 days. The sequential group was treated with rabeprazole and amoxicillin for 5 days and then rabeprazole, clarithromycin, and metronidazole for an additional 5 days. Six weeks after the treatment period, patients in both groups underwent 13C-Urea breath test (UBT) to confirm H. pylori eradication. Results. The eradication rate was 90.3% in the concomitant group and 85.5% in the sequential group. However, the eradication rates between the two groups showed no statistical difference (P=0.343). Conclusion. No statistical difference was found in eradication rates between the two groups. However, in areas where antibiotic resistance is high, concomitant therapy may be more effective than sequential therapy for H. pylori eradication.http://dx.doi.org/10.1155/2016/1293649
spellingShingle Sung Min Jung
Dae Young Cheung
Jin Il Kim
Il Kim
Hyeonjin Seong
Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
Gastroenterology Research and Practice
title Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
title_full Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
title_fullStr Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
title_full_unstemmed Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
title_short Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
title_sort comparing the efficacy of concomitant therapy with sequential therapy as the first line therapy of helicobacter pylori eradication
url http://dx.doi.org/10.1155/2016/1293649
work_keys_str_mv AT sungminjung comparingtheefficacyofconcomitanttherapywithsequentialtherapyasthefirstlinetherapyofhelicobacterpylorieradication
AT daeyoungcheung comparingtheefficacyofconcomitanttherapywithsequentialtherapyasthefirstlinetherapyofhelicobacterpylorieradication
AT jinilkim comparingtheefficacyofconcomitanttherapywithsequentialtherapyasthefirstlinetherapyofhelicobacterpylorieradication
AT ilkim comparingtheefficacyofconcomitanttherapywithsequentialtherapyasthefirstlinetherapyofhelicobacterpylorieradication
AT hyeonjinseong comparingtheefficacyofconcomitanttherapywithsequentialtherapyasthefirstlinetherapyofhelicobacterpylorieradication